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Background: Understanding the mechanisms underlying bacterial-driven inflammation and neutrophil recruitment is important to design better
therapies for CF. CXCL8 is an important chemokine found elevated in the airways of CF patients that recruits neutrophil to sites of the
inflammation.
Methods: Airway epithelial cells (AECs) expressing wild-type CFTR or CFTRΔF508 were challenged with Pseudomonas aeruginosa diffusible
material (PsaDM) and the synthesis of CXCL8 was measured by quantitative real-time PCR and ELISA in absence or presence of MAPK
inhibitors, TLR antagonists, glutathione and a NADPH oxidase inhibitor.
Results: CFTRΔF508 AECs secrete more CXCL8 in response to PsaDM than their wild type counterpart, which can be reversed by addition of
extracellular glutathione or incubating AECs at 27 °C to favour folding and expression of CFTR at the cell membrane. Moreover, in CFTRΔF508
AECs, TLR2, TLR4 and TLR5 act redundantly to drive CXCL8 synthesis via the activation of NADPH oxidase.
Discussions: These results demonstrate that NADPH oxidase is necessary for CXCL8 synthesis in response to TLRs activation by P. aeruginosa.
© 2010 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Cytokines; Reactive oxygen species; MAPK; Cystic fibrosis; Gene expression1. Introduction
Defective CF transmembrane conductance regulator (CFTR)
function is responsible for CF lung disease, the most life-
threatening complication of CF, characterized by mucus hyper
secretion and neutrophil-dominated inflammation. Intensity of
airway neutrophilia was shown to be associated with decreasing
lung functions as measured by the decline in FEV1 [1].
Unfortunately, diseases associated with neutrophilic inflammation
are generally found to be poorly responsive to glucocorticoids
while patients are still susceptible to their side effects, highlighting
the need for alternative treatments [2]. Neutrophils can be attracted
to sites of inflammation from the circulation via the action of
chemo-attractants of the Cys-Xaa-Cys chemokine family, such as⁎ Corresponding author. Meakins-Christie Laboratories, 3626 St-Urbain,
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doi:10.1016/j.jcf.2010.11.005CXCL8 (also known as IL-8) [3], which has been found elevated in
the airways of CF patients [4].
Secretion of CXCL8 by airway epithelial cells can occur
upon infection to initiate the innate immune response.
Pseudomonas aeruginosa (Psa) is the most commonly found
pathogen in the airways of chronically infected CF patients.
Moreover, Psa is also the predominant pathogen encountered
during exacerbation episodes, which have a profound effect on
the patient's quality of life [5]. Human cells detect pathogens in
part through Pathogen-Recognition Receptors (PRRs) such as
the Toll-Like Receptors (TLRs) and Nucleotide-binding
Oligomerization Domain (NOD)-like receptor (NLR) families.
Once activated, these receptors will engage various intracellular
signalling pathways responsible for host responses to infection
(reviewed in [6]). Among the major signalling pathways
activated in response to motile gram negative bacteria like Psa
are the NFκB and MAPK pathways.
We have recently shown that in airway epithelial cells
expressing the most common mutation in CF (CFTRΔF508)d by Elsevier B.V. All rights reserved.
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greater sensitivity to ROS, hyper-activation of the p38 and ERK
MAPKs and increased IL-6 synthesis [8]. In this manuscript we
have investigated the impact of the CFTRΔF508 mutation on the
synthesis of the neutrophil chemo-attractant CXCL8 in response
to P. aeruginosa diffusible material.2. Materials and methods
2.1. Materials
The CFTR inhibitor, GlyH-101 was purchased from EMD
Biosciences (NJ, USA). DPI (diphenyliodonium chloride) was
bought from Sigma-Aldrich (Ontario, Canada). All other
materials were purchased from sources previously reported
[8]. The P. aeruginosa diffusible material (PsaDM) was
prepared from late stationary phase Psa (mucoid strain 508)
isolated from the sputum of a patient with CF (Hôpital Sainte-
Justine, Montréal) as previously reported [8].2.2. Neutralizing antibodies
Neutralizing antibodies against TLR2, TLR4 and TLR5 were
used at 5 μg/ml and purchased from Invivogen (CA, USA).
CXCL8 neutralizing antibody was used at 50 μg/ml and
purchased from R&D systems (Minneapolis, USA).2.3. Cell culture
Human airway epithelial cell line NuLi derived from a
normal lung of a 36-year-old male patient and CuFi derived
from the lung of a 14-year-old female patient with cystic
fibrosis homozygous for the CFTRΔF508 mutation were
generously provided by Dr Emmanuelle Brochiero (Centre de
Recherche, Hôtel-Dieu du CHUM, Université de Montréal,
Canada) and were cultured as described previously [8]. For
CFTR temperature rescue experiments, NuLi and CuFi were
seeded at 2.5×105 cells/cm2, grown until near confluence and
then incubated at 27 °C for 30 h. The cells were incubated for
1 h at 37 °C prior to stimulation with PsaDM.2.4. Neutrophil chemotaxis assay
Neutrophil migration assays were performed as described
previously [8].2.5. ELISA
Human CXCL8 DuoSet ELISA kit (DY208) was purchased
from R&D Systems (MN, USA). A 10 times supernatant
dilution collected after cell stimulation was used for CXCL8
quantification according to manufacturer's protocol.2.6. RNA extraction and cDNA synthesis, quantitative real-time
PCR and mRNA stability assays
These methods were all performed as described previously [8]
using the following sense and antisense primers: CXCL8 (5′-
GTGCAGTTTTGCCAAGGAGT-3′; 5′-CTCTGCACC-
CAGTTTTCCTT-3′), and GAPDH (5′-AGCAATGCCTCCTG-
CACCACC-3′; 5′-CCGGAGGGGCCATCCACAGTC-3′).2.7. Statistical analysis
ANOVA followed by a multiple comparison test (Bonfer-
roni) were used to test differences in mean between groups.
P valuesb0.05 were considered significant.3. Results
3.1. PsaDM-driven CXCL8 levels are higher in AECS
expressing the CFTRΔF508 mutation
P. aeruginosa is mostly found in the lungs of CF patients as
intra-luminal masses distal from airway epithelial cells [9].
Therefore, Psa diffusible material (PsaDM) represents a model
of the pathogenic factors encountered by AECs. Upon exposure
to PsaDM, AECs expressing the most common mutation
encountered in CF, CFTRΔF508, secrete more CXCL8 than
cells expressing wild-type CFTR (Fig. 1A). This increased
secretion of CXCL8 by CFTRΔF508 AECs is the result of both
increased transcription (Fig. 1B) and enhanced mRNA stability
(Fig. 1C). Moreover, PsaDM-driven CXCL8 synthesis is
dependent on the ERK1/ERK2 and p38 MAPKs in both non-
CF and CF AECs (Fig. 1A and B), as demonstrated by pre-
incubating cells with the p38 MAPK inhibitor BIRB0796 [10]
or the MKK1/MKK2 inhibitor PD184352 [11]. MKK1/MKK2
are direct upstream activators of ERK1/ERK2 [12]. This is in
accordance with previous results obtained for CXCL8 in airway
epithelial cells stimulated by TLR agonists [13] or IL-6
synthesis in response to PsaDM [8].
In the initial secreted cytokine array performed to identify p38
MAPK-dependent cytokines secreted upon PsaDM challenge in
AECs, CXCL8 enhanced secretion had not been clearly detected
and became apparent only with a more detailed and robust
analysis combining quantitative real-time PCR and ELISA. This
prompted us to investigate the other p38 MAPK-dependent
cytokines up regulated by PsaDM in AECs that were initially
found in the screen: GM-CSF, RANTES and LTα [8]. For these
three cytokines, no significant up-regulation was detected in both
non-CF and CF AECs upon PsaDM challenge (Supplementary
Fig. 1). Therefore in the AEC model investigated, IL-6 and
CXCL8 are the major cytokines up regulated in a p38 MAPK-
dependent fashion upon PsaDM challenge.
As CXCL8 is a powerful chemo-attractant for neutrophils,
we looked at its contribution to the chemotactic potential of
PsaDM-stimulated AECs medium. Neutralizing CXCL8 action
with an antibody at concentrations shown to be effective
previously [14], led to a clear reduction of neutrophils
Fig. 1. MAPK-dependent CXCL8 synthesis is higher in CFTRΔF508 compared
to their wild type counterpart in response to PsaDM. Non-CF (white bars) and
CFTRΔF508 (black bars) AECs were left untreated or pre-treated for 1 h with
0.1 μM BIRB0796 (A, B) or 2 μM PD184352 (A, B) and exposed to 3 h
PsaDM. (C) Alternatively, following a 3 h PsaDM stimulation, 5 mg/mL
Actinomycin D was added to block transcription and the RNA extracted at
various intervals thereafter from 30 min to 360 min. The amount of CXCL8
mRNA (B, C) was determined by quantitative real-time PCR and the presence of
CXCL 8 in the supernatant (A) quantified by ELISA. *=pb0.05, compared to
respective control; #=pb0.05, Compared to PsaDM stimulation.
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AECs (Fig. 2).
3.2. Increased CXCL8 secretion in response to PsaDM is
dependent on the loss of functional CFTR in AECs
As the two immortalized cell lines used in this study come
from different genetic backgrounds, it was important to assess
whether the differences were due to the loss of functional CFTR
or the contribution of other genetic factors. It has been
previously reported that incubating AECs carrying the
CFTRΔF508 mutation at lower temperatures favours correct
folding of the protein and promotes its functional expression at
the cell membrane [15]. Incubating both AECs lines at 27 °C for
30 h prior to restoring the temperature to 37 °C and exposure to
PsaDM abolished the difference in CXCL8 synthesis observed
in the CFTRΔF508 AECs (Fig. 3A). Conversely, incubating
AECs expressing wild-type CFTR in the presence of GlyH-101,
a CFTR inhibitor, for 1 or 3 days prior to exposure to PsaDM
led to a significant increase in CXCL8 synthesis (Fig. 3B).
Taken together these experiments link the absence of functional
CFTR to increase CXCL8 synthesis in response to PsaDM.
3.3. Multiple TLRs act redundantly in driving CXCL8 synthesis
by CFTRΔF508 AECs exposed to PsaDM
PsaDM may contain one or more agonists contributing to
CXCL8 synthesis. Among the various bacteria derived products
commercially available, a triacylated synthetic lipoprotein
(Pam3CSK4) that activates TLR1/TLR2, LPS from P. aerugi-
nosa that activates TLR4, flagellin from Salmonella typhimur-
ium that activates TLR5 or C12-ie-DAP an acylated derivative
of the dipeptide γ-D-Glu-mDAP, present in the peptidoglycan
(PGN) of bacteria that activates the intracellular receptorFig. 2. CXCL8 is an important but not sole driver of neutrophil chemotaxis of
AECs stimulated by PsaDM. Neutrophils chemotaxis was assayed in presence of
PsaDM (3 h) treated Non-CF (white bars) and CFTRΔF508 (black bars) AECs
conditioned medium (PsaDM). The contribution of CXCL8 was determined by
the addition of a neutralizing antibody (aCXCL8, 50 ug/ml). *=pb0.05,
compared to respective PsaDM stimulation.
Fig. 4. CFTRΔF508 induced CXCL8 in response to PsaDM through the action
of multiple redundant TLRs. Non-CF (white bars) and CFTRΔF508 (black bars)
AECs were incubated with 20 ng/ml IL-17A, 1 μg/ml C12-ie-DAP (C12),
100 ng/ml LPS and 1 μg/ml Pam3CSK4 (PAM), 10 ng/ml flagellin (Flag) or
PsaDM all for 3 h (A). Non-CF (B) and CFTRΔF508 (C) AECs were pre-treated
for 30 min with 50 μg/ml neutralizing antibodies against TLR2, TLR5 and/or
TLR4 and exposed for 3 h to PsaDM (B, C). The presence of CXCL8 in the
supernatant was quantified by ELISA. Results from two independent
experiments are shown. *=pb0.05, compared to respective control.
Fig. 3. Enhanced CXCL8 synthesis in response to PsaDM is linked with loss of
functional CFTR. (A) Non-CF (white bars) and CFTRΔF508 (black bars) AECs
were incubated at 27 °C or 37 °C for 30 h before they were left to recuperate for
1 h at 37 °C. AECs were then left untreated (-) or exposed for increasing length
of times to PsaDM as indicated. The amount of CXCL8 mRNA was determined
by quantitative real-time PCR. Results from three independent experiments are
shown *=pb0.05, CFTRΔF508 compared to wild-type CFTR; #=pb0.05,
37 °C compared to 27 °C. (B) Non-CF AECs were left untreated or incubated in
the presence of 20 μM GlyH-101 for 1 (1d) or 3 (3d) days prior to exposure to
PsaDM (+) for 3 h. The presence of CXCL8 in the supernatant was quantified by
ELISA.
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potently in the CFTRΔF508 AECs than in the non-CF
counterpart (Fig. 4A). The cells were also stimulated with IL-
17A, a cytokine driving neutrophil recruitment to inflamed
areas via the synthesis of CXCL8 [16], but in this case, non-CF
AECs were more responsive, indicating that enhanced cytokine
secretion in CFTRΔF508 AECs appears specific to bacterial-
derived products. The more potent agonists were those
activating TLR2 and TLR5.
In order to check whether these TLRs contributed to the
synthesis of CXCL8 by PsaDM, we prevented TLR2, TLR4 and
TLR5 activation with neutralizing antibodies. Neutralizing TLR2
or TLR4 had a weak effect on CXCL8 secretion, whereas
neutralizing TLR5 was more potent in non-CF AECs (Fig. 4B).
Combining all three neutralizing antibodies showed no additive
effect compared to blocking TLR5 alone (Fig. 4B). In contrast, in
CFTRΔF508 cells, although each neutralizing antibody had a
partial effect on CXCL8 synthesis upon exposure to PsaDM
(Fig. 4C), combining all three antibodies brought the CXCL8
levels back to those observed in the non-CF cells (Fig. 4B and C).Therefore the up-regulation of CXCL8 synthesis in CFTRΔF508
AECs is occurring through the action of multiple TLRs acting
redundantly.
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AECs in response to PsaDM
In CFTRΔF508 AECs, lower concentrations of the anti-
oxidant glutathione in the extracellular media, lead to hyper
activation of the ERK1/ERK2 and p38 MAPK pathways and
enhanced IL-6 synthesis [8]. We found that similarly, adding
glutathione to theCFTRΔF508AECsmediumgreatly diminished
the synthesis of CXCL8 (Fig. 5A). Additionally, in the case of IL-
6, intracellular ROS generation was found to be essential for its
synthesis in response to PsaDMby an uncharacterizedmechanism
[8]. We looked at NADPH oxidase as a plausible enzyme
generating ROS following TLR activation [17]. Non-phagocytic
cells have NADPH oxidases that are sensitive to the action of the
pharmacological inhibitor diphenyliodonium chloride (DPI) [18].
Therefore, we checked whether NADPH oxidase played a role in
response to PsaDM. Pre-treating CFTRΔF508 AECs with
increasing concentration of DPI, greatly reduced CXCL8
transcription with doses as low as 3 μM (Fig. 5B). These results
suggest that NADPH oxidase is an important component of the
innate immune response of AECs to P. aeruginosa.Fig. 5. NADPH oxidase is essential for CXCL8 synthesis by CFTRΔF508
AECs in response to PsaDM. Non-CF (white bars) and CFTRΔF508 (black
bars) AECs were left untreated or pre-treated for 15 min with 10 mM
extracellular glutathione (GSH) (A), or 30 min with increasing concentrations
of DPI (B) and exposed 3 h to PsaDM. (A) After stimulation, the amount of
CXCL8 mRNAwas determined by quantitative real-time PCR *=pb0.05, GSH
compared to PsaDM. B. The presence of CXCL8 in the supernatant was
quantified by ELISA. *=pb0.05, compared to control; #=pb0.05, compared to
PsaDM stimulation.4. Discussion
In this manuscript we have shown that loss of functional
CFTR leads to enhanced CXCL8 synthesis upon exposure to
PsaDM in a TLRs and NADPH oxidase-dependent fashion. In
many, but not all CF models, AECs respond to P. aeruginosa
with increased or prolonged IL-6 and CXCL8 synthesis [19].
Moreover, freshly harvested cells from inflamed CF lungs
showed evidence of enhanced cytokine production [20]. This
matches the clinical observations that pro-inflammatory cyto-
kines, TNFα, IL-1β, IL-6 and CXCL8 are all found elevated in
the airways of CF patients accompanied by increased
neutrophilia [4], although an intrinsic increased inflammatory
response of AECs expressing the CFTRΔF508 mutation is still
much debated. We have recently showed that increased IL-6
synthesis in CFTRΔF508 AECs is the result of enhanced
MAPK activation leading to increased mRNA transcription and
stability. In this manuscript we have found that similar to IL-6,
but to a lesser extent, CXCL8 is also increased at both the
transcriptional and post-transcriptional level in a MAPK-
dependent fashion. Moreover, we have linked the functional
absence of CFTR to increased CXCL8 synthesis using a
reconstitution model in CFTRΔF508 AECs and a CFTR
inhibitor in wild-type CFTR AECs. This means that the major
changes observed in our cell culture model were not due to
differences in the genetic background of the two cell lines.
However, other genes as well as epigenetic factors were shown
to have an important impact on CF [21], which may be lost in ex
vivo and in vitro assays.
Although many similarities were found between CXCL8 and
IL-6 synthesis in response to PsaDM in both CFTRΔF508 and
non-CF AECs, including their dependence on MAPK pathways
for transcriptional activation, a number of interesting differences
were also revealed. First, whereas neutralizing IL-6 in the
conditioned medium of CFTRΔF508 cells brought the chemo-
taxis of neutrophil back to the non-CF levels, CXCL8 was found
to potently inhibit neutrophil recruitment in both CFTRΔF508
and non-CFAECs.Moreover, CXCL8 synthesis by CFTRΔF508
AECs is downstream of multiple redundant TLRs (TLR2, TLR4
and TLR5), whereas IL-6 synthesis is dependent on one or more
additional pathways [8]. These results would have a clear impact
on therapeutic strategies aimed at targeting only one or both of
these important inflammatory cytokines. They also suggest that
attempts at preventing inflammation by targeting a single TLR
may not be as efficient as predicted. It is therefore essential to
identify common signalling events leading to inflammatory
mediator production to find more efficient ways to interfere with
inflammation. When three different pattern-recognition receptors
(TLR2, TLR3 and NOD1) acting through distinct adaptor
molecules are activated by their respective ligands in AECs they
convey signals towards common signalling modules that regulate
the synthesis of CXCL8 [13]. This convergence mechanism to
signalling module frommultiple cellular receptors was also found
in a systems biology study of RAW macrophages [22].
A common mechanism may be the dependence of the
response to the generation of ROS. Therefore we have
investigated the potential role of a well-known enzymatic
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can be activated following TLR stimulation [17]. Once
activated, NADPH oxidase catalyses the transfer of electrons
from NADPH to molecular oxygen, forming O2− [23]. Here we
report that DPI, a relatively specific inhibitor of NADPH
oxidase, blocked CXCL8 transcription in response to PsaDM.
Although we cannot discard that other proteins modified by DPI
mediate this effect, it highlights a common pathway down-
stream of TLR receptors leading to CXCL8 synthesis.
Moreover, this may provide an explanation for the difference
we observed between TLR and IL-17 initiated responses; TLR-
signalling may be more sensitive than the IL-17Rs to the pro-
oxidative shift observed in CFTRΔF508 AECs.
Taken together our results suggest that in order to block
CXCL8 synthesis, individual TLR may not be ideal targets, but
targeting ROS or NAPDH oxidase may be a more attractive
strategy. Moreover, these findings support the notion that ROS
are very important intermediates of the lung inflammatory
response to multiple insults [24], including CF [25]. Therapies
aimed at increasing the anti-oxidant potential of AECs or
neutralizing the action of ROS may be beneficial to decrease
inflammation in chronic lung diseases. However a careful
monitoring of the adverse impact on the innate immune system
capacity to deal with invading pathogens will be needed.
Supplementary materials related to this article can be found
online at doi:10.1016/j.jcf.2010.11.005.
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